These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 16387077
41. Successful treatment of 115 pediatric renal transplant recipients with tacrolimus-based immunosuppressive therapy: a 7-year multicenter study in Japan. Hasegawa A, Oshima S, Takahashi K, Uchida K, Ito K, Sonoda T. Transplant Proc; 2005 May; 37(4):1769-70. PubMed ID: 15919460 [Abstract] [Full Text] [Related]
42. Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation. Jung GO, Chun JM, Park JB, Choi GS, Kwon CH, Joh JW, Lee SK, Kim SJ. Transplant Proc; 2008 Sep; 40(7):2339-41. PubMed ID: 18790229 [Abstract] [Full Text] [Related]
43. A matched cohort pharmacoepidemiological analysis of steroid free immunosuppression in renal transplantation. Barraclough KA, Landsberg DN, Shapiro RJ, Gill JS, Li G, Balshaw RF, Chailimpamontree W, Keown PA, Genome Canada Biomarkers in Transplantation Group. Transplantation; 2009 Mar 15; 87(5):672-80. PubMed ID: 19295311 [Abstract] [Full Text] [Related]
44. [Impact of some immunological and non-immunological factors on early and distant function of transplanted kidney]. Sierńko J. Ann Acad Med Stetin; 2004 Mar 15; 50(1):53-67. PubMed ID: 16871744 [Abstract] [Full Text] [Related]
45. Outcome of kidney transplantation for renal amyloidosis:a single-center experience. Celik A, Saglam F, Dolek D, Sifil A, Soylu A, Cavdar C, Temizkan A, Bora S, Gulay H, Camsari T. Transplant Proc; 2006 Mar 15; 38(2):435-9. PubMed ID: 16549141 [Abstract] [Full Text] [Related]
46. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation. Sevmis S, Emiroglu R, Karakayali F, Yagmurdur MC, Dalgic A, Moray G, Haberal M. Transplant Proc; 2005 Sep 15; 37(7):3016-8. PubMed ID: 16213290 [Abstract] [Full Text] [Related]
47. Two decades of experience with cyclosporine in renal transplantation in Helsinki. Salmela KT, Kyllönen LE. Transplant Proc; 2004 Mar 15; 36(2 Suppl):94S-98S. PubMed ID: 15041315 [Abstract] [Full Text] [Related]
48. Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis. Kolonko A, Pinocy-Mańdok J, Kocierz M, Kujawa-Szewieczek A, Chudek J, Malyszko J, Malyszko JS, Myśliwiec M, Wiecek A. Transplant Proc; 2009 Oct 15; 41(8):3046-51. PubMed ID: 19857673 [Abstract] [Full Text] [Related]
49. Renal grafts from elderly donors: histological studies and long-term results. Rossetti O, Soldano S, Aseni P, Colombo V, Roselli E, De Gasperi A, Sansalone CV. Transplant Proc; 2007 Oct 15; 39(6):1820-2. PubMed ID: 17692621 [Abstract] [Full Text] [Related]
50. Two-day induction with thymoglobulin in kidney transplantation: risks and benefits. Uslu A, Nart A, Coker I, Köse S, Aykas A, Kahya MC, Yüzbaşioğlu MF, Doğan M. Transplant Proc; 2004 Oct 15; 36(1):76-9. PubMed ID: 15013305 [Abstract] [Full Text] [Related]
51. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients. Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M. Transplant Proc; 2009 Jun 15; 41(5):1604-8. PubMed ID: 19545689 [Abstract] [Full Text] [Related]
52. Thirty years of kidney transplantation in two Chinese centers. Tan J, Qiu J, Lu T, Liu Z, Guo Y, Zhang S, Tang X. Clin Transpl; 2005 Jun 15; ():203-7. PubMed ID: 17424737 [Abstract] [Full Text] [Related]
53. Cadaveric renal transplantation: the Chennai experience. Prabahar MR, Soundararajan P. Transplant Proc; 2008 May 15; 40(4):1104-7. PubMed ID: 18555124 [Abstract] [Full Text] [Related]
54. Living-unrelated (paid) renal transplantation--ten years later. Ivanovski N, Popov Z, Cakalaroski K, Masin J, Spasovski G, Zafirovska K. Transplant Proc; 2005 Mar 15; 37(2):563-4. PubMed ID: 15848457 [Abstract] [Full Text] [Related]
55. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience. Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M. Saudi J Kidney Dis Transpl; 2008 Jul 15; 19(4):564-70. PubMed ID: 18580014 [Abstract] [Full Text] [Related]
56. Cadaveric donor factor variations during a 12-year period: influence on kidney transplant outcomes. Nunes P, Parada B, Pratas J, Roseiro A, Figueiredo A, Macário F, Rolo F, Mota A. Transplant Proc; 2006 Jul 15; 38(6):1867-9. PubMed ID: 16908308 [Abstract] [Full Text] [Related]
57. Effect of the shipment of cadaveric renal allografts on allograft survival. Kessler M, Virion JM, Hachicha M, Moulin B, Toupance O, Rebibou JM, Guillemin F. Nephrol Dial Transplant; 2008 Mar 15; 23(3):1054-60. PubMed ID: 17971383 [Abstract] [Full Text] [Related]
58. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Luke PP, Herz DB, Bellinger MF, Chakrabarti P, Vivas CA, Scantlebury VP, Hakala TR, Jevnikar AM, Jain A, Shapiro R, Jordan ML. Transplantation; 2003 Dec 15; 76(11):1578-82. PubMed ID: 14702527 [Abstract] [Full Text] [Related]
59. Living unrelated renal donation: the University of Wisconsin experience. D'Alessandro AM, Pirsch JD, Knechtle SJ, Odorico JS, Van der Werf WJ, Collins BH, Becker YT, Kalayoglu M, Armbrust MJ, Sollinger HW. Surgery; 1998 Oct 15; 124(4):604-10; discussion 610-1. PubMed ID: 9780978 [Abstract] [Full Text] [Related]